Predictors of Bicuspid Aortic Valve-Associated Aortopathy in Childhood: A Report From the MIBAVA Consortium by Grattan, Michael et al.
Western University 
Scholarship@Western 
Paediatrics Publications Paediatrics Department 
3-1-2020 
Predictors of Bicuspid Aortic Valve-Associated Aortopathy in 
Childhood: A Report From the MIBAVA Consortium 
Michael Grattan 
Andrea Prince 
Rawan K Rumman 
Conall Morgan 
Michele Petrovic 
See next page for additional authors 
Follow this and additional works at: https://ir.lib.uwo.ca/paedpub 
 Part of the Pediatrics Commons 
Authors 
Michael Grattan, Andrea Prince, Rawan K Rumman, Conall Morgan, Michele Petrovic, Amanda Hauck, 
Luciana Young, Anders Franco-Cereceda, Bart Loeys, Salah A Mohamed, Harry Dietz, Seema Mital, Chun-
Po Steve Fan, Cedric Manlhiot, Gregor Andelfinger, and Luc Mertens 
Circ Cardiovasc Imaging. 2020;13:e009717. DOI: 10.1161/CIRCIMAGING.119.009717 March 2020 1
Michael Grattan, MD, 
MSc
Andrea Prince, BSc







Bart Loeys, MD, PhD




Chun-Po Steve Fan, PhD
Cedric Manlhiot, PhD
Gregor Andelfinger, MD, 
PhD
Luc Mertens , MD, PhD
on behalf of MIBAVA 
Leducq Consortium
See Editorial by Simpson
BACKGROUND: Bicuspid aortic valve (BAV) is the most prevalent 
congenital heart defect affecting 1% to 2% of the population. It is 
associated with ascending aorta dilatation. Valve morphology, aortic 
stenosis (AS), and aortic insufficiency (AI) have been proposed as potential 
risk factors; however, evaluating their role is difficult, as these factors are 
inherently related. The aim of this study was to determine whether BAV 
morphology and dysfunction are independent determinants for ascending 
aorta dilatation in pediatric patients.
METHODS: A multicenter, retrospective, cross-sectional study of 
pediatric BAV patients followed since 2004 was performed. Imaging 
data were assessed for BAV morphology, severity of AS and AI, history of 
coarctation, and aortic dimensions. Associations were determined using 
multivariable regression analysis. A subset of patients undergoing aortic 
interventions (balloon dilation or Ross) were assessed longitudinally.
RESULTS: Data were obtained from 2122 patients (68% male; median 
age 10.2 years). Fifty percent of patients had ascending aorta dilatation. 
Right and noncoronary cusp fusion, increasing AS and AI, and older age 
were independently associated with ascending aorta dilatation. A history 
of coarctation was associated with less ascending aorta dilatation. In 
patients with neither AS nor AI, 37% had ascending aorta dilatation 
(4% severe). No complications related to aortic dilatation occurred in this 
cohort. Aortic Z scores were determined, and a Z-score calculator was 
created for this population.
CONCLUSIONS: In this large pediatric cohort of patients with BAV, 
valve morphology, AS, and AI are independently associated with 
ascending aorta dilatation, suggesting that hemodynamic factors 
influence aortopathy. However, even in BAVs with no AS or AI, there is 
significant ascending aorta dilatation independent of valve morphology. 
Interventions that led to changes in degree of AI and AS did not seem 
to influence change in aortic dimensions. The current BAV cohort can 
be used as a reference group for expected changes in aortic dimensions 
during childhood. © 2020 American Heart Association, Inc.
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Bicuspid aortic valve (BAV) is the most common congenital heart defect with a prevalence of ≈1.4%.1,2 It is commonly associated with aortic 
valve dysfunction and coarctation of the aorta (CoA) 
and has been linked to ascending aorta dilatation.3 Less 
commonly, BAV has been linked to dilatation of the 
more proximal aortic sinuses. Patients with BAV are at 
increased risk of complications due to ascending aorta 
dilatation including aortic dissection.4
The cause of ascending aorta dilatation in pediatric 
patients with BAV is not clear and may involve valve 
characteristics (morphology and dysfunction),5 inherent 
abnormalities in the arterial vascular structure,6 abnor-
mal flow dynamics,7 and genetic variations.8 Evaluating 
the role of valve characteristics as potential risk fac-
tors for ascending aorta dilatation has been difficult, 
as BAV morphology and function are inherently relat-
ed.5,9,10 While some of these factors have been stud-
ied in adults with BAV, less information is available in 
the pediatric population.11 Ascending aorta dilatation 
progresses with age and younger patients with signifi-
cant dilatation can thus be considered as a more severe 
presentation of the same disease. Predisposing factors 
contributing to ascending aorta dilatation may also be 
different in this younger group.
In adults, both genetic and hemodynamic factors 
have been described to contribute to BAV aortopathy, 
with different factors contributing to different patterns 
of aortic dilatation.2 In pediatric patients, the hemody-
namic factors mainly relate to valve morphology and 
valve dysfunction, as additional comorbidities such as 
hypertension are less relevant. The primary objective 
of the current study was to determine whether BAV 
morphology, valve function, and a history of CoA are 
independently related to ascending aorta dilatation 
in a large cohort of pediatric patients. Our secondary 
objectives were to determine whether these factors 
are independently related to aortic sinus dilatation, to 
determine the relationships between valve morphology, 
valve function and the presence of CoA, and to deter-
mine the influence of aortic valve interventions (bal-
loon dilation and Ross procedure) on the progression of 
aortic dilatation over time. We also sought to generate 
aortic nomograms for patients with BAV that can be 
used as a reference for patient follow-up. We hypoth-
esized that aortic valve morphology (specifically right 
and noncoronary cusp [R-N] fusion) and valve dysfunc-
tion (both aortic stenosis [AS] and insufficiency) would 
be associated with ascending aorta dilatation and that 




The MIBAVA (Mechanistic Interrogation of BAV-associated 
Aortopathy) Leducq consortium is an international research 
collaborative with the goal of determining the cause of 
ascending aorta dilatation in patients with BAV. Within this 
consortium, we created a registry of patients with BAV fol-
lowed at the participating centers. This registry was used to 
conduct a multicenter, retrospective, cross-sectional study of 
all pediatric patients followed with BAV at the Mechanistic 
Interrogation of BAV-associated Aortopathy centers, further 
expanded to include patients followed at the Ann & Robert 
H. Lurie Children’s Hospital, Chicago, IL. Children 0 to 17.9 
years of age diagnosed with BAV who underwent at least 
one echocardiogram between July 1, 2004, and January 31, 
2016, were included. Exclusion criteria for registry inclu-
sion were (1) BAV associated with interrupted aortic arch or 
complex congenital heart disease requiring single ventricle 
palliation and (2) patients with BAV who underwent aor-
tic valve replacement or aortic root/ascending aorta repair 
or replacement before the first available echocardiogram. 
Exclusion criteria for detailed analysis and Z-score creation 
also included patients with known genetic syndromes, those 
with associated congenital heart disease requiring surgery 
(with the exception of coarctation), and those with signifi-
cant congenital heart disease affecting the left heart (mitral 
valve disease, sub-AS). A subset of patients who underwent 
CLINICAL PERSPECTIVE
Bicuspid aortic valve is known to be associated 
with aortic valve dysfunction and ascending 
aorta dilatation. Although patients with bicuspid 
aortic valve are known to have an increased risk 
for aortic dissection, the precise mechanism and 
risk factors for this complication are not entirely 
clear. Thus, the implications of aortic dilatation, 
especially in younger patients with bicuspid aor-
tic valve are not known. This article describes 
an association between aortic valve dysfunction 
(both stenosis and insufficiency) with ascending 
aorta dilatation. Although no causal relationships 
could be confirmed, this association will provide 
important information to young patients that may 
be at higher risk of progressive aortic dilatation 
depending on their valve function. The Z scores 
that were generated and Z-score calculator that 
was created will help practitioners determine the 
relative severity of aortic dilatation in their specific 
patients. Given the lack of aortic complications in 
this cohort, no strict cutoffs for surgical interven-
tion can be recommended; however, providing a 
benchmark to compare patients against will remain 
helpful given the known association between aor-
tic dilatation severity and dissection. Moreover, 
dedicated Z scores for patients with bicuspid aortic 
valve are more likely to pick up extreme pheno-
types and outliers compared with existing Z scores 
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aortic valve intervention (balloon dilation or Ross procedure) 
at a single center (Hospital for Sick Children) were analyzed 
longitudinally for changes in aortic dimensions over time. 
Patients were included in longitudinal analysis if they under-
went aortic valve balloon dilation or Ross procedure and had 
at least 3 echocardiograms available for analysis post-proce-
dure. Mean duration of follow-up for patients in both groups 
was 4.7±2.8 years.
The data that support the findings of this study are avail-
able from the corresponding author upon reasonable request. 
This study was approved by the institutional review commit-
tees of each participating institution. No informed consent 
was required.
Measurements
Investigators at each center analyzed echocardiograms to 
determine BAV morphology, aortic dimensions (annulus, 
sinus, sinotubular junction, and ascending aorta), and the 
presence and severity of AS, AI, and CoA. Echocardiograms 
before any aortic valve intervention were used to determine 
valve morphology. Aortic dimensions and Z scores were 
determined from the last echocardiogram before any aor-
tic valve or root intervention. A subset of patients (n=119) 
was included that underwent surgical aortic valve repair (but 
not replacement) or balloon dilation before 2004. In these 
patients, the last echocardiogram before any additional inter-
vention was analyzed. In patients undergoing longitudinal 
analysis, every echocardiogram post-balloon dilation or Ross 
procedure was analyzed. No further analysis was performed 
after a patient underwent a subsequent aortic valve replace-
ment or aortic root repair.
Valve morphology was classified according to presumed 
leaflet fusion: right and left coronary cusp (R-L) fusion, R-N 
fusion, or left and noncoronary cusp fusion (Figure 1A). If the 
valve was unicuspid or the morphology was unclear, it was 
excluded from further analysis.
Measurements of the maximal (mid-systolic) aortic dimen-
sions were acquired from the parasternal long-axis view at 
the level of the valve annulus, aortic sinuses, sinotubular 
junction, and ascending aorta at the level of the right pul-
monary artery (Figure  1B). Measurements were converted 
into Z-scores based on the hospital for sick children Z-scores 
(Table I in the Data Supplement). One of the study sites (site 
2) used the leading-edge technique, while all other sites used 
the inner-edge technique. Due to this discrepancy, 50 patient 
echocardiograms from site 2 were randomly chosen to have 
their measurements repeated using the inner-edge technique. 
Using Bland-Altman analysis, there were no significant dif-
ferences between measurement techniques (P value 0.48 for 
the aortic sinus and 0.58 for the ascending aorta), and there 
was minimal bias (Figure I in the Data Supplement), thus, the 
entire cohort was included for analysis. Z scores are standard 
in pediatric echocardiographic interpretation given the signifi-
cant differences in patient size. Aortic dilatation was defined 
as a Z score ≥2, while significant dilatation was defined as a 
Z score ≥4. The specific pattern of dilatation was described 
according to involvement of both the aortic sinuses and 
ascending aorta (type 1), ascending aorta alone (type 2), or 
aortic sinuses alone (type 3).2 Severity of AS was quantified 
from the highest reported mean instantaneous pressure gradi-
ent obtained using continuous wave Doppler. Gradients were 
stratified according to severity based on previously published 
guidelines (none <10 mm Hg; mild, 10–25 mm Hg; moder-
ate, 25–40 mm Hg; and severe, >40 mm Hg).12 AI severity was 
determined from the echocardiography report, with readers 
quantifying AI severity based on previously published guide-
lines.13 The presence of CoA on echocardiogram was deter-
mined from the echocardiography report, based on isthmus 
dimension, peak instantaneous gradient across the isthmus 
and the abdominal aorta Doppler flow pattern.
Clinical Profile
Patient charts were reviewed to determine the cardiac history 
including associated congenital heart disease, prior surgical or 
interventional procedures, complications, and the presence of 
genetic syndromes known to affect the aorta.
Statistics
Continuous variables were reported as mean and SD except 
for age, which was not normally distributed and was 
reported as median and interquartile range. Dichotomous 
and polytomous variables were summarized using frequen-
cies. Between-group differences in continuous variables were 
assessed using 1-way ANOVA with F tests or Wilcoxon rank-
sum tests. Between-group differences in categorical variables 
were assessed using Fisher exact tests. Outcome variables 
(aortic sinus, sinotubular junction, and ascending aorta Z 
scores) were assessed both as continuous variables and as 
Figure 1. Bicuspid aortic valve (BAV) morphology and aortic measurements.
A, BAV fusion patterns. B, Measurement locations of the aortic sinuses and ascending aorta. 1, aortic annulus; 2, aortic sinus; 3, sinotubular junction; and 4, 
ascending aorta. A separate high parasternal view was often used to visualize the ascending aorta. L-N indicates left and noncoronary cusp; R-L, right and left 
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dichotomous variables using +2 and +4 as the threshold val-
ues (ie, dilated Z score >2 or dilated Z score >4 versus nondi-
lated Z score <2).
Multivariable linear regression was applied to quantify the 
adjusted associations of independent variables, including BAV 
morphology, severity of AS and insufficiency, a history of CoA, 
and age, with each Z-score outcome variable. Both 95% CIs 
and P values were evaluated based on t statistics.
Next, we developed Z-score models using the LMS method 
(Lambda, Mu, Sigma)14 for the maximal aortic valve annulus, 
sinus of Valsalva, and ascending aorta dimensions in rela-
tion to body surface area. For a given distribution, the LMS 
method assesses and quantifies the changes in a distribution by 
parametrizing the location (Median, mu), coefficient of varia-
tion (sigma), and skewness (lambda) using generalized additive 
models. The (possibly nonlinear) associations with the indepen-
dent variable (ie, body surface area) were separately modeled 
and quantified for each of the parameters using cubic splines, 
which were estimated using a penalized likelihood method. 
Given the nonnegative nature of the dimensions, we consid-
ered 3 distributions, namely Box-Cox Cole and Green, Box-Cox 
power exponential,15 and t-distributions16 and selected the 
one with the optimal Akaike information criteria. To extend 
the applicability of this method, a web app was developed for 
BAV Z-score calculation (https://sickkidscvdmc.shinyapps.io/
MIBAVA_normogram/).
For the longitudinal analysis, we separately analyzed the 
post-balloon and post-Ross longitudinal echo data in patients 
with moderate-to-severe versus no or mild aortic insufficiency. 
We used the independent estimating equation models to 
assess and quantify the association of aortic insuffciency with 
aortic annulus, aortic sinus, sinotubular junction, and ascend-
ing aorta dimensions. We assessed the time trend using 
natural cubic spline, but the nonlinear time trends were not 
significant for any of the outcome variables. Hence, we pre-
sented the results of the models with a linear trend. The stan-
dard errors were estimated using robust sandwich estimators.
Significance level of 5% was applied to all analyses. 
Data analysis was conducted using SAS v9.4 (SAS Statistical 
Software, Cary, NC) and R v3.4.1 (R Foundation for Statistical 
Computing, Vienna, Austria).
RESULTS
Data were obtained from 2122 pediatric patients (0–
17.9 years) followed at 5 institutions. Patient demo-
graphics and clinical characteristics are shown in Table 1. 
One hundred seventy-one patients were excluded due 
to the presence of genetic syndromes, and 388 patients 
were excluded due to the presence of significant con-
genital heart disease leaving a total of 1564 patients for 
cross-sectional analysis. For the longitudinal analysis, 
309 echocardiograms from 53 patients were included 
in the balloon dilation group, and 116 echocardiograms 
from 21 patients were included in the Ross procedure 
group. Balloon dilation was performed at a median age 
of 0.6 years (range, 0–16.0 years), and Ross procedure 
was performed at a medium age of 10.6 years (range, 
0.6–17.2 years). Of note, no complications related to 
aortic dilation occurred in this cohort.
Valve Morphology and Function
The most common BAV morphology was R-L fusion 
(65.7%) followed by R-N fusion (32.9%). There were 
no significant differences in the frequency of differ-
ent valve morphology between males and females. 
One hundred forty-nine patients had indeterminate or 
unicuspid valve morphology and were excluded from 
further analysis. Overall, 308 (14.4%) patients had at 
least moderate AS and 122 (5.6%) had at least moder-
ate AI. R-L fusion was associated with CoA, while R-N 
fusion was associated with AS and AI (Table II in the 
Data Supplement).
Aortic Sinus and Ascending Aorta 
Dilatation
Fifty percent of patients had aortic sinus or ascend-
ing aorta dilatation, or both with the majority having 
isolated ascending aorta dilatation. Nine percent of 
patients had significant aortic sinus or ascending aorta 
dilatation, or both (Z score ≥4; Table 1). There were no 
differences in the number of males and females with 
ascending aorta dilatation (48.9% versus 46.7%), but 
there were slightly more males with aortic sinus dila-
tation compared with females (12.4% versus 7.7%, 
P=0.001). There were no differences in Z scores when 
comparing site 2 to the other study sites.
In univariable analysis, R-L fusion was associated 
with a larger aortic sinus, while R-N fusion was associ-
ated with a larger ascending aorta (Table III in the Data 
Supplement). Increasing AS severity was associated 
with a smaller aortic sinus and a larger ascending aorta, 
while increasing AI severity was associated with a larger 
aortic sinus and ascending aorta (Table IV in the Data 
Supplement). A history of CoA was inversely associated 
with aortic sinus and ascending aorta dilatation (Table 
V in the Data Supplement). Valve morphology (R-N 
fusion), severity of AS, severity of AI, and absence of 
CoA were positively associated with type 1 or 2 dilata-
tion, while valve morphology (R-L fusion) was positively 
associated with type 3 dilatation (Tables III through V in 
the Data Supplement).
Among the 496 patients with neither AS nor AI, 
the mean ascending aorta Z score was 1.6±1.3, with 
36.5% of patients having ascending aorta dilatation 
and 3.6% having an ascending aorta Z score ≥4. 
There were no differences in the ascending aorta Z 
score based on valve morphology within this group 
(Figure  2; R-L fusion mean 1.51, R-N fusion mean 
1.77, P value 0.17).
The results of the multivariable regression analysis 
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Figure II in the Data Supplement. Similar to univariable 
analysis, valve morphology (R-L fusion) and severity of 
AI were independently associated with aortic sinus dila-
tation. Severity of AS and a history of CoA were each 
inversely associated with aortic sinus dimension.
The results of the multivariable regression analysis 
for ascending aorta dimension are shown in Table  2 
and Figure III in the Data Supplement. Similar to uni-
variable analysis, valve morphology (R-N fusion), AI, 
and AS were independently associated with ascending 
aorta dilatation. A history of CoA was inversely associ-
ated with ascending aorta dimension. The severity of 
ascending aorta dilatation increased with age.
The dimension of the sinotubular junction correlated 
with the dimension of the aortic sinus, while there was 
less correlation between the dimension of the sinotubu-
lar junction and ascending aorta (Figure IV in the Data 
Supplement). The relationship between BAV morphology 
and valve function with sinotubular junction dimension 
was similar to that of the aortic sinus (data not shown).
The results of the longitudinal analysis following 
balloon dilation are shown in Table 3. Independent of 
AI severity, there was no significant progression in the 
aortic valve annulus, sinus of Valsalva, sinotubular junc-
tion, or ascending aorta Z scores over time. Patients 
with moderate-to-severe AI were more likely to have 
a larger aortic annulus, aortic sinus, and sinotubular 
junction. The results of the longitudinal analysis fol-
lowing Ross procedure are shown in Figure  3. In the 
first 5 years following the Ross procedure, there was a 
mild increase in aortic annulus and sinotubular junction 
Z scores (P=0.008 and P<0.001, respectively). The aor-
tic sinus and ascending aorta Z scores remained stable 
Table 1. Baseline Clinical Characteristics of the Study Population Were 
Summarized
N Mean (SD)
Age at echo, y (median, IQR) 2122 10.2 (3.9–15.2)
Sex 2122  
  Male  1445 (68.1%)
  Female  677 (31.9%)
Medical history
  Known cardiac genetic disorder 2122 171 (8.1%)
   Turner  48
   Marfan  7
   Loeys Dietz/Ehlers Danlos  2
   Other  114
  Aortic valve fusion type 1974*  
   R-L  1294 (65.6%)
   R-N  652 (33.0%)
   L-N  28 (1.4%)
  History of AS 2113  
   Any AS  743 (35.2%)
   Mild  375 (17.7%)
   Moderate  141 (6.7%)
   Severe  222 (10.5%)
  History of AI 2113  
   Any AI  1129 (53.4%)
   Mild  965 (45.7%)
   Moderate  112 (5.3%)
   Severe  51 (2.4%)
Aortic dilatation (Z score >2.0)
  Any dilatation 2122 1058 (49.9%)
  Aortic sinus 2107 229 (10.9%)
  Sinotubular junction 1278 125 (9.8%)
  Ascending aorta 2081 998 (48%)
Severe aortic dilatation (Z score >4.0)
  Any dilatation 2122 194 (9.1%)
  Aortic sinus 2107 18 (0.9%)
  Sinotubular junction 1278 9 (0.7%)
  Ascending aorta 2081 184 (8.8%)
Aortic dilatation type 2074  
  Type 1  172 (8.1%)
  Type 2  822 (38.9%)
  Type 3  53 (2.5%)
Associated cardiac disease 2122  
  Any cardiac disease  757 (35.7%)
  Coarctation of aorta  544 (25.6%)
  Sub-aortic stenosis  58 (2.7%)
  Atrial septal defect  207 (9.8%)
  Ventricular septal defect  239 (11.2%)
  Mitral valve disease  142 (6.7%)
  Other  85 (4.0%)
AI indicates aortic insufficiency; AS, aortic stenosis; IQR, interquartile range; 
L-N, left and noncoronary cusp fusion; R-L, right and left coronary cusp fusion; 
R-N, right and noncoronary cusp fusion; Type 1, aortic sinus and ascending aorta 
dilatation; Type 2, isolated ascending aorta dilatation; and Type 3 isolated aortic 
sinus dilatation.
*One hundred forty-eight patients had unknown, indeterminate, or possibly 
unicuspid valve morphology.
Figure 2. Ascending aorta Z score in patients with no aortic stenosis 
(AS) or aortic insufficiency (AI).
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(Figure 3A through 3D). Patients post-balloon dilation 
and post-Ross procedure had similar rates of change in 
absolute aortic dimensions and aortic Z scores.
Nomograms for the aortic valve annulus, sinus of 
Valsalva, and ascending aorta dimensions versus body 
surface area are shown in Figure 4. The parameter func-
tions were estimated nonparametrically, thus there is 
no simple equation to calculate aortic Z scores. We have 
developed a web application which will allow the user 
to calculate the Z score based on the patient’s height, 
weight, and aortic dimension (https://sickkidscvdmc.
shinyapps.io/MIBAVA_normogram/).
DISCUSSION
In this study, we examined the relationship between 
BAV morphology, valve function, and CoA with ascend-
ing aorta and aortic sinus dimensions in a large cohort 
of pediatric patients. We found a high incidence of 
ascending aorta dilatation with about 50% of all 
patients having ascending aorta Z scores ≥2 and 9% 
having ascending aorta Z scores ≥4. AI and AS severity 
are independently associated with significant ascend-
ing aorta dilatation. AI severity is independently asso-
ciated with aortic sinus dilatation, while AS severity is 
independently associated with a smaller aortic sinus. 
R-N fusion is associated with increased valve dysfunc-
tion (AI and AS) but also independently associated with 
ascending aorta dilatation. R-L fusion is associated with 
CoA and aortic sinus dilatation, while CoA is indepen-
dently associated with less dilatation of the aortic sinus 
and ascending aorta. Patients with significant AI post-
balloon dilation had more aortic dilatation at baseline; 
however, there was little progression over time and 
the rate of dilatation was similar to patients without 
significant AI post-balloon dilation. Patients post-Ross 
procedure had an initial period of progressive dilatation 
followed by stabilization of aortic Z scores.
There are 2 main hypotheses on the pathophysiol-
ogy of BAV aortopathy. The first is that hemodynamic 
and rheological factors are responsible for progressive 
aortic dilatation. The concept of post-stenotic dilatation 
is based on the presence of elevated mechanical wall 
stress caused by an upstream flow disturbance. Several 
MRI flow studies have suggested that flow disturbances 
related to valve dysfunction but also valve morphology 
alone cause abnormal localized aortic wall stress result-
ing in eccentric aortic wall remodeling.17–20 The second 
hypothesis suggests a genetic cause resulting in intrin-
sic aortic wall abnormalities, although identifying spe-
cific genes has proven challenging.21,22 Obviously both 
hypotheses are not mutually exclusive as there may be 
interactions between genetic and hemodynamic fac-
tors. Moreover, patients with BAV may prove to be 
diverse with a subgroup of patients in whom genetic 
factors may be more important. From this perspective, 
it is interesting to study bicuspid aortopathy in a pedi-
atric age group as it may help to better understand the 
different factors contributing to aortic dilatation.
A first interesting observation from our study was 
the independent association between valve morphol-
ogy (R-N fusion) and ascending aorta dilatation. R-N 
fusion is known to be associated with valve dysfunction, 
with increased rates of AI and AS,23 a finding confirmed 
in our pediatric cohort. Previous pediatric studies have 
failed to show any independent association between 
valve morphology and ascending aortic dilatation, with 
associations observed on univariable analysis likely sec-
ondary to the effect of valve morphology on valve dys-
function.5,10 However, the smaller size of these studies 
may have limited their ability to detect subtle associa-
tions. Recent 4-dimensional MRI flow data suggest that 
even in the absence of AS, R-N fusion results in sig-
nificant flow disturbance in the ascending aorta.7 The 
independent association that we observed between 
R-N fusion and ascending aorta dilatation may be relat-
ed to low-velocity flow disturbances. This requires fur-
ther study in pediatric patients where comorbidities are 
less important.
Our data support that valve dysfunction is an impor-
tant determinant of aortopathy in the pediatric popula-
Table 2. Multivariable Linear Regression Analysis for Aortic Sinus and 
Ascending Aorta Dilatation
Aortic Sinus* 
Coef (95% CI) P Value
Ascending 
Aorta* Coef 
(95% CI) P Value
BAV fusion type (ref: R-L)
  R-N −0.446  
(−0.589 to −0.303)
<0.001 0.174  
(0.019 to 0.329)
0.028
  L-N −0.090  
(−0.671 to 0.490)
0.76 0.123  
(−0.488 to 0.733)
0.69
AS severity (ref: no AS)
  Mild −0.547  
(−0.780 to −0.314)
<0.001 0.280  
(0.027 to 0.532)
0.030
  Moderate −0.493  
(−0.802 to −0.184)
0.002 0.758  
(0.422 to 1.094)
<0.001
  Severe −0.702  
(−0.957 to −0.447)
<0.001 0.862  
(0.585 to 1.138)
<0.001
AI severity (ref: no AI)
  Mild 0.260  
(0.091 to 0.430)
0.003 0.121  
(−0.062 to 0.304)
0.194
  Moderate 1.080  
(0.680 to 1.479)
<0.001 0.837  
(0.406 to 1.268)
<0.001
  Severe 1.921  
(1.480 to 2.363)
<0.001 0.934  
(0.449 to 1.418)
<0.001
Coarctation −0.262  
(−0.429 to −0.095)
0.002 −0.751  
(−0.932 to −0.569)
<0.001
Age, y 0.032  
(0.020 to 0.043)
<0.001 0.018  
(0.006 to 0.031)
0.004
AI indicates aortic insufficiency; AS, aortic stenosis; BAV, bicuspid aortic 
valve; L-N, left and noncoronary cusp fusion; R-L, right and left coronary cusp 
fusion; and R-N, right and noncoronary cusp fusion.
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tion. Previous pediatric studies have consistently shown 
a relationship between AI severity and ascending aorta 
dilatation.5,9,10 However, there are conflicting results 
regarding the impact of AS, with most groups failing to 
show an independent relationship using multivariable 
analysis.5,10 Our data confirm the relationship between 
AI and ascending aorta dilatation. We also found an 
independent relationship between AS and ascending 
aorta dilatation. AI and AS are often present together, 
making their individual assessment difficult. Our large 
Table 3. Independent Estimating Equation Models for Aortic Dimensions Following Balloon Dilation
Variable
Aortic Valve 
Annulus Z Score, 
Coef (95% CI) P Value
Aortic Sinus Z 
Score, Coef  
(95% CI) P Value
Sinotubular 
Junction Z Score, 
Coef (95% CI) P Value
Ascending Aorta Z 
Score, Coef  





<0.001 1.099  
(0.167 to 2.030)
0.021 1.552  
(0.398 to 2.707)







0.31 0.005  
(−0.039 to 0.048)
0.82 0.051  
(−0.068 to 0.171)







0.47 0.004  
(−0.086 to 0.094)
0.93 −0.042  
(−0.179 to 0.095)
0.55 0.030  
(−0.135 to 0.195)
0.72
AI indicates aortic insufficiency.
Figure 3. The progression of aortic Z scores over time in patients post-Ross procedure.
A, Aortic valve annulus Z score; B, sinus of Valsalva Z score; C, sinotubular (ST) junction Z score; and D, ascending aorta Z score. Thick line indicates independent 
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sample size may have allowed us to more accurately 
identify the independent associations of AS and AI with 
ascending aorta dimension.
Despite the association between valve dysfunction 
and aortopathy, we also demonstrated that children 
with normally functioning BAVs had increased mean 
ascending aorta Z scores, unrelated to valve morphol-
ogy. Moreover, in patients post-aortic balloon dilation, 
there were no significant differences in the subsequent 
rate of aortic enlargement based on the presence of 
significant AI. These observations suggest that there is 
an underlying abnormality increasing the likelihood of 
ascending aorta dilatation that is further exacerbated by 
valve morphology and dysfunction. Studies in patients 
with normal BAV function suggest the presence of flow 
abnormalities in the ascending aorta in patients with 
aortic dilatation. These abnormalities may be related to 
inherent vascular dysfunction,6 abnormal flow dynam-
ics7 or an underlying genetic predisposition,8 and are 
subject to ongoing investigation.
The presence of CoA was associated with significant-
ly less aortic sinus, sinotubular junction, and ascending 
aorta dilatation. The relationship between CoA and 
aortic dilatation in patients with BAV has not been well 
defined. Fernandes et.al5 found a similar relationship 
with ascending aorta dimension but no relationship 
to aortic sinus dimension. R-L fusion is known to be 
associated with a higher incidence of CoA.23 This fusion 
pattern is also independently associated with larger 
aortic sinus dimensions, possibly confounding prior 
investigations with smaller sample sizes. CoA is known 
to be associated with hypoplasia of the aortic arch and 
ascending aorta,24 and recent studies suggest that even 
after early repair, precoarctation arteries are thicker and 
stiffer compared with controls.25 Abnormalities in vas-
cular function have been detected in neonates before 
surgery, suggesting the possibility of an underlying pri-
mary vasculopathy.26 These differences may restrict ves-
sel growth and aneurysm formation. Patients with BAV 
and CoA may represent a different disease population. 
The findings in children seem to contrast with 2 recent 
adult studies suggesting that CoA is a risk factor for 
ascending aortic complications in patients with BAV.27,28 
This requires further study but confounding factors 
may include residual arch obstruction and chronic 
hypertension.
BAV is also associated with aortic sinus dilatation, 
although at a much lower rate than ascending aorta 
dilatation. R-L fusion and AI severity are independently 
associated with aortic sinus dilatation, while AS sever-
ity is independently associated with a smaller aortic 
sinus dimension.5,9,29 Our results show a similar relation-
ship, although we suspect that the influence of BAV 
morphology on aortic sinus dimension may be overes-
timated. Standard echocardiographic measurements 
from the parasternal long-axis view do not visualize 
the entire sinus enface,30 and the elliptical aortic sinus 
shape specifically observed with R-L fusion may lead to 
overestimation of the sinus dimension when standard 
measurement techniques are applied.31 Regarding valve 
function, it remains unclear whether aortic sinus dilata-
tion is secondary to AI or whether AI is secondary to a 
dilated aortic sinus.5,32 Larger longitudinal studies with 
cross-sectional (CT or MR) imaging are needed to fur-
ther examine this relationship.
The majority of patients exhibited type 2 dilatation, 
involving dilatation of the ascending aorta alone. In con-
trast, adults most commonly exhibit type 1 dilatation 
involving both the ascending aorta and aortic sinuses.2 
Type 1 dilatation has been found to be most common 
in older adults and in those with R-L fusion.2 Howev-
er, we found that both type 1 and type 2 dilatation 
were associated with R-N fusion. As discussed above, 
the influence of R-L fusion on aortic sinus dimension 
needs further clarification. The increased incidence of 
type 1 dilatation in adults may be secondary to abnor-
mal aortic flow or a genetic predisposition that makes 
the aortic sinuses more susceptible to progressive dila-
Figure 4. Nomograms showing the relationship between body surface area and aortic dimensions.
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tation over time.33 There may be distinct differences in 
the cause of BAV-associated aortopathy in pediatric and 
adult patient populations.
The clinical significance of these findings is impor-
tant regarding prediction of further dilatation and 
possible thresholds for valve and ascending aorta inter-
ventions. If flow disturbance is the main contributing 
factor to progressive aortopathy this may influence 
timing of valve interventions but may also necessitate 
surgical strategies that aim to normalize flow patterns 
in the aorta. The addition of aortic Z scores for patients 
with BAV may contribute to this decision-making pro-
cess. Although no patients in our cohort had an aor-
tic complication, these Z scores will help practitioners 
determine the relative significance of aortic dilatation 
in this complex population.
Limitations
This study has limitations. Patients were identified in 
tertiary care centers, leading to possible referral bias for 
more severe aortic valve disease, and a higher incidence 
of CoA. Although our large sample size allowed us to 
investigate progression of disease and we followed a 
subset of the population longitudinally, we did not fol-
low all patients longitudinally to determine their spe-
cific rates of aortic growth. Aortic sinus measurements 
obtained as per published echocardiographic guide-
lines may underestimate or overestimate dimensions 
compared with cross-sectional imaging due to sinus 
asymmetry. Two different measurement techniques 
for the aortic dimensions were used. However, we did 
not observe that measurement technique significantly 
altered the measured aortic dimensions in a random 
subset of 50 patients. The classification of aortic regur-
gitation severity is not quantitative may be subjec-
tive, especially when multiple institutions are making 
measurements. Lastly, this study did not evaluate the 
specific mechanisms for ascending aortic dilatation in 
patients with and without valve dysfunction.
Conclusions
Patients with BAV have a high incidence of significant 
ascending aorta dilatation. More severe AI and AS are 
independently associated with ascending aorta dilata-
tion, although even patients with normal valve func-
tion have increased ascending aorta Z scores. After 
controlling for valve dysfunction, R-N fusion remains 
independently associated with ascending aorta dila-
tation. The presence of CoA in patients with BAV is 
inversely associated with aortic sinus and ascending 
aorta dimensions. Following aortic valve balloon dila-
tion aortic Z scores remain stable in patients with and 
without significant AI. Immediately after Ross proce-
dure, aortic Z scores increase slightly but then stabi-
lize within 5 years. We propose that pediatric patients 
with BAV have an underlying abnormality increasing 
their susceptibility to ascending aorta dilatation that 
is further exacerbated by valve dysfunction. Ongoing 
study is required to determine the precise mechanisms 
of ascending aorta dilatation in patients with and with-
out valve dysfunction.
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